Latest Breaking News On - Jiangsu alphamab oncology - Page 1 : comparemela.com

AIM Vaccine conducted a very small IPO on the Hong Kong exchange, raising US$20 million, which netted the company only US$10 million. The IPO saw less than 1% of the company's shares sold.

China
Germany
Australia
Shanghai
Hong-kong
Singapore
Beijing
Cambridge
Cambridgeshire
United-kingdom
France
Chinese